Literature DB >> 12666074

Practice recommendations for the use of L-carnitine in dialysis-related carnitine disorder. National Kidney Foundation Carnitine Consensus Conference.

Garabed Eknoyan1, Derrick L Latos, Jill Lindberg.   

Abstract

References are not cited within this report. However, they are included in the supplement to this issue of the American Journal of Kidney Diseases, which contains reports regarding each topic that was considered by the panel. These recommendations are not intended to be guidelines or standards of care. Instead, they have been developed to provide the best available information and expert opinion in decision-making for the clinician. The recommendations should not be considered as prescribing an exclusive course of management.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12666074     DOI: 10.1016/s0272-6386(03)00110-0

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  22 in total

Review 1.  The use of levo-carnitine in children with renal disease: a review and a call for future studies.

Authors:  Brook Belay; Nora Esteban-Cruciani; Christine A Walsh; Frederick J Kaskel
Journal:  Pediatr Nephrol       Date:  2005-12-23       Impact factor: 3.714

2.  Effect of carnitine supplementation on lipid profile and anemia in children on chronic dialysis.

Authors:  Enrico Verrina; Ubaldo Caruso; Maria Grazia Calevo; Francesco Emma; Palma Sorino; Tommaso De Palo; Giancarlo Lavoratti; Laura Turrini Dertenois; Michela Cassanello; Roberto Cerone; Francesco Perfumo
Journal:  Pediatr Nephrol       Date:  2007-02-03       Impact factor: 3.714

Review 3.  An Introduction to Pharmacotherapy for Inborn Errors of Metabolism.

Authors:  Aaron A Harthan
Journal:  J Pediatr Pharmacol Ther       Date:  2018 Nov-Dec

4.  L-carnitine treatment in incident hemodialysis patients: the multicenter, randomized, double-blinded, placebo-controlled CARNIDIAL trial.

Authors:  Lucile Mercadal; Mathieu Coudert; Anne Vassault; Laurence Pieroni; Alain Debure; Messaoud Ouziala; Hélène Depreneuf; Christine Fumeron; Aude Servais; Nader Bassilios; Jacques Bécart; Ubald Assogba; Mahmoud Allouache; Boussad Bouali; Nhan Luong; Marie Paul Dousseaux; Sophie Tezenas-du Montcel; Gilbert Deray
Journal:  Clin J Am Soc Nephrol       Date:  2012-08-30       Impact factor: 8.237

5.  Effect of hemodialysis session on the dynamics of carnitine ester profile changes in L-carnitine pretreated end-stage renal disease patients.

Authors:  Botond Csiky; Judit Bene; Istvan Wittmann; Endre Sulyok; Bela Melegh
Journal:  Int Urol Nephrol       Date:  2012-06-10       Impact factor: 2.370

Review 6.  Inflammation and L-carnitine therapy in hemodialysis patients: a review.

Authors:  Saman Khalatbari-Soltani; Hadi Tabibi
Journal:  Clin Exp Nephrol       Date:  2014-12-02       Impact factor: 2.801

Review 7.  Use of agents stimulating erythropoiesis in digestive diseases.

Authors:  Rosario Moreno López; Beatriz Sicilia Aladrén; Fernando Gomollón García
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

8.  L-Carnitine status in end-stage renal disease patients on automated peritoneal dialysis.

Authors:  Lorenzo Di Liberato; Arduino Arduini; Claudia Rossi; Augusto Di Castelnuovo; Cosima Posari; Paolo Sacchetta; Andrea Urbani; Mario Bonomini
Journal:  J Nephrol       Date:  2014-03-06       Impact factor: 3.902

Review 9.  The effects of L-carnitine supplementation on indicators of inflammation and oxidative stress: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Hadis Fathizadeh; Alireza Milajerdi; Željko Reiner; Elaheh Amirani; Zatollah Asemi; Mohammad Ali Mansournia; Jamal Hallajzadeh
Journal:  J Diabetes Metab Disord       Date:  2020-09-15

10.  Differential effects of oral and intravenous l-carnitine on serum lipids: is the microbiota the answer?

Authors:  Maria Dolores Sanchez-Niño; Alberto Ortiz
Journal:  Clin Kidney J       Date:  2014-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.